companies innovating obesity treatment glp-1 drugs 2025 Amgen Reshapes the Drug Market with Innovative MariTide The future of GLP-1s: Cost,

Regardless of drugs, lifestyle matters: physical activity, healthy diet, sleep, social connection, cognitive engagementall are evidence-based pillars of brain health

When GLP-1 receptor agonists (GLP-1RAs) were first approved over a decade ago, their primary indication was simple: help people with Type 2 diabetes manage their blood sugar

Personalized medical support can prevent or mitigate these symptoms, improving adherence and the overall success of the therapy

We used version 2 of the Cochrane risk-of-bias tool for randomised trials to assess risk of bias for the primary outcome

Nearly 20% of sites prescribed #GLP-1 receptor agonists based on upper-body photos alone